Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) …
…, PA Ganz, SE Reis, W McCaskill-Stevens… - Jama, 2006 - jamanetwork.com
ContextTamoxifen is approved for the reduction of breast cancer risk, and raloxifene has
demonstrated a reduced risk of breast cancer in trials of older women with osteoporosis.…
demonstrated a reduced risk of breast cancer in trials of older women with osteoporosis.…
Update of the national surgical adjuvant breast and bowel project study of tamoxifen and raloxifene (STAR) P-2 trial: preventing breast cancer
…, PA Ganz, SE Reis, W McCaskill-Stevens… - Cancer prevention …, 2010 - AACR
The selective estrogen-receptor modulator (SERM) tamoxifen became the first US Food and
Drug Administration (FDA)–approved agent for reducing breast cancer risk but did not gain …
Drug Administration (FDA)–approved agent for reducing breast cancer risk but did not gain …
Relationships between the Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS), and clinical/polysomnographic measures in a community sample
…, TW Kamarck, J Owens, L Lee, SE Reis… - Journal of clinical …, 2008 - jcsm.aasm.org
Study Objectives: 1) To characterize PSQI and ESS scores, and their relationship to each
other, in an adult community sample; 2) To determine whether PSQI and ESS scores, in …
other, in an adult community sample; 2) To determine whether PSQI and ESS scores, in …
Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with …
CN Bairey Merz, LJ Shaw, SE Reis, V Bittner… - Journal of the American …, 2006 - jacc.org
Coronary heart disease is the leading cause of death and disability in the US, but recent
advances have not led to declines in case fatality rates for women. The current review highlights …
advances have not led to declines in case fatality rates for women. The current review highlights …
Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia: results from the National Heart, Lung and …
CJ Pepine, RD Anderson, BL Sharaf, SE Reis… - Journal of the American …, 2010 - jacc.org
Objectives : We investigated whether coronary microvascular dysfunction predicts major
adverse outcomes during follow-up among women with signs and symptoms of ischemia. …
adverse outcomes during follow-up among women with signs and symptoms of ischemia. …
Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom …
LJ Shaw, CN Bairey Merz, CJ Pepine, SE Reis… - Journal of the American …, 2006 - jacc.org
Despite a dramatic decline in mortality over the past three decades, coronary heart disease
is the leading cause of death and disability in the US Importantly, recent advances in the field …
is the leading cause of death and disability in the US Importantly, recent advances in the field …
Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study
SE Reis, R Holubkov, AJC Smith, SF Kelsey… - American heart …, 2001 - Elsevier
… Author links open overlay panel Steven E. Reis MD, a , Richard Holubkov PhD, a , AJConrad
Smith MD, a , Sheryl F. Kelsey PhD, a , Barry L. Sharaf MD, b , Nathaniel Reichek MD, c , …
Smith MD, a , Sheryl F. Kelsey PhD, a , Barry L. Sharaf MD, b , Nathaniel Reichek MD, c , …
Withdrawn: postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free …
…, BD Johnson, V Vaccarino, SE Reis… - The Journal of …, 2008 - academic.oup.com
Background: Women with polycystic ovary syndrome (PCOS) have a greater clustering of
cardiac risk factors. However, the link between PCOS and cardiovascular (CV) disease is …
cardiac risk factors. However, the link between PCOS and cardiovascular (CV) disease is …
Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study
…, SF Kelsey, LJ Shaw, WJ Rogers, SE Reis - Circulation, 2004 - Am Heart Assoc
Background— Obesity and the metabolic syndrome frequently coexist. Both are associated
with cardiovascular disease (CVD). However, the contribution of obesity to cardiovascular risk…
with cardiovascular disease (CVD). However, the contribution of obesity to cardiovascular risk…
Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women
…, SE Reis, BL Sharaf, LJ Shaw, E Handberg… - Jama, 2004 - jamanetwork.com
ContextIndividual contributions of obesity and physical fitness (physical activity and
functional capacity) to risk of coronary heart disease in women remain unclear.ObjectiveTo …
functional capacity) to risk of coronary heart disease in women remain unclear.ObjectiveTo …
